XML 19 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Mar. 29, 2019
Mar. 30, 2018
Cash Flows from Operating Activities:    
Net earnings attributable to the Group $ 192,363 $ 54,493
Depreciation and amortization:    
Property, equipment and improvements 43,812 59,139
Intangible assets 37,963 36,048
(Gain) Loss on disposal of businesses and investments 0 (444)
Stock based compensation 28,916 47,189
Equity in earnings of operating ventures, net (5,325) 787
(Gain) Losses on disposals of assets, net 3,730 3,917
Loss (Gain) on pension and retiree medical plan changes (34,621) 3,819
Deferred income taxes (31,008) 6,799
Changes in assets and liabilities, excluding the effects of businesses acquired:    
Receivables and contract assets (252,731) (171,912)
Prepaid expenses and other current assets 47,733 (2,361)
Accounts payable (6,754) 17,972
Accrued liabilities (57,763) (20,625)
Contract liabilities 57,881 33,599
Other deferred liabilities (48,761) (17,420)
Other, net (30,667) 3,204
Net cash (used for) provided by operating activities (55,232) 54,204
Cash Flows Used for Investing Activities:    
Additions to property and equipment (61,480) (44,845)
Disposals of property and equipment and other assets 7,240 428
Distributions of capital from (contributions to) equity investees (3,904) (7,696)
Acquisitions of businesses, net of cash acquired 0 (1,484,817)
Proceeds (payments) related to sales of businesses 0 3,403
Purchases of noncontrolling interests 1,113 0
Net cash used for investing activities (59,257) (1,533,527)
Cash Flows Provided by Financing Activities:    
Proceeds from long-term borrowings 1,648,903 3,058,088
Repayments of long-term borrowings (949,176) (1,495,887)
Proceeds from short-term borrowings 1 699
Repayments of short-term borrowings (4,157) (699)
Debt issuance costs (3,741) 0
Proceeds from issuances of common stock 25,945 26,636
Common stock repurchases (488,435) (2,951)
Taxes paid on vested restricted stock (20,317) (17,140)
Cash dividends, including to noncontrolling interests (56,390) (44,233)
Net cash provided by (used for) financing activities 152,633 1,524,513
Effect of Exchange Rate Changes 19,136 16,074
Net Increase in Cash and Cash Equivalents 57,280 61,264
Cash and Cash Equivalents at the Beginning of the Period 793,358 774,151
Cash and Cash Equivalents at the End of the Period 850,638 835,415
Less Cash and Cash Equivalents included in Assets held for Sale (176,090) (164,612)
Cash and Cash Equivalents of Continuing Operations at the End of the Period $ 674,548 $ 670,803